Julien Taieb, Debora Basile, Jenny Seligmann, Guillem Argiles, Thierry André, Claire Gallois, Richard M Goldberg, Greg Yothers, Alberto Sobrero, Jeffrey A Meyerhardt, John Souglakos, Roberto Labianca, Tim Iveson, David N Church, Dirk Arnold, Jeanne Tie, Sharlene Gill, Pierre Laurent-Puig, Takayuki Yoshino, Sara Lonardi, Qian Shi
BACKGROUND: Despite contributions provided by the recent clinical trials, several issues and challenges still remain unsolved in adjuvant colon cancer (CC). Hence, further studies should be planned to better refine risk assessment as well as to establish the optimal treatment strategy in the adjuvant setting. However, it is necessary to request adequate, contemporary and relevant variables and report them homogeneously in order to bring maximal information when analyzing their prognostic value...
May 15, 2024: European Journal of Cancer